ENTITY
InnoCare Pharma Ltd

InnoCare Pharma Ltd (9969 HK)

96
Analysis
Health Care • China
InnoCare Pharma Limited researches, develops, manufactures, and distributes pharmaceuticals. The Company produces antibiotic drugs, respiratory drugs, cardiovascular drugs, vitamin tablets, health care drugs, and other related products. InnoCare Pharma markets its products throughout China.
more
bullish•InnoCare Pharma Ltd
•11 Feb 2020 00:32

InnoCare Pharma IPO Initiation: Promising Prognosis

InnoCare Pharma Ltd (1576300D CH) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...

Logo
500 Views
Share
bullish•Kilcoy Global Foods
•02 Feb 2020 12:25

ECM Weekly (2 Feb 2020) - Smoore, Innocare, Kilcoy Global, Mr. DIY

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. ECM...

Share
bullish•InnoCare Pharma Ltd
•28 Jan 2020 12:49

InnoCare (čÆŗčÆšå„åŽ) Pre-IPO: Thoughts on Valuation

InnoCare Pharma Limited is a clinical-stage biopharmaceutical company with a focus on small molecule inhibitors for BTK, and FGFRs. The company...

Logo
618 Views
Share
bullish•InnoCare Pharma Ltd
•21 Oct 2019 10:13

InnoCare (čÆŗčÆšå„åŽ) Pre-IPO: A Decent Team but Short of Clinical Stage Candidates

InnoCare Pharma Limited is a clinical-stage biopharmaceutical company with a focus on small molecule inhibitors for BTK, and FGFRs.Ā We will discuss...

Logo
640 Views
Share
x